MO HB2817

Creates the "Veterans Mental Health Innovation Act" establishing a grant program through the Department of Health and Senior Services to fund FDA-overseen clinical trials on ibogaine for treating opioid use disorder, co-occurring substance use disorders, and other neurological or mental health conditions

Grant recipients must be Missouri-based entities with neurosurgery programs, cardiac intensive care capabilities, and proven neurological research experience, and must secure matching funds equal to the grant amount from non-state sources

Creates two state treasury funds: the "Ibogaine Study Fund" for grant awards and the "Ibogaine Intellectual Property Fund" to collect revenue from any commercial rights arising from the trials, with IP fund proceeds dedicated to programs assisting veterans and at-risk populations

Requires quarterly progress and financial reports from grant recipients to the department, and annual reports from the department to the General Assembly before December 1st each year

If FDA approves ibogaine, only physicians licensed under chapter 334 may prescribe it, and administration must be supervised at a hospital or licensed health care facility; grant applications must be accepted beginning November 1, 2026